ScholarIQanswers from OpenAlex & ORCID
Karen Kelly
ResearcherPublications, citations & collaboration network
Karen Kelly is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Karen Kelly have?
ScholarIQindexed works
Karen Kelly has 686 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Karen Kelly have?
ScholarIQcitation count
Karen Kelly has 21,723 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Karen Kelly?
ScholarIQh-index
Karen Kelly has an h-index of 70 in OpenAlex.
What is the i10-index of Karen Kelly?
ScholarIQi10-index
Karen Kelly has an i10-index of 245 in OpenAlex.
What is the ORCID of Karen Kelly?
ScholarIQorcid
The ORCID for Karen Kelly is on the source record.
What is the OpenAlex record for Karen Kelly?
ScholarIQopenalex
The OpenAlex for Karen Kelly is on the source record.
What are the most-cited papers on Karen Kelly?
ScholarIQmost cited works
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor Ganti, Billy W. Loo, M. Bassetti, Collin M. Blakely, Anne C. Chiang, Thomas A. D’Amico, Christopher D’Avella, Afshin Dowlati, Robert J. Downey, Martin J. Edelman, Charles Florsheim, Kathryn A. Gold, Jonathan W. Goldman, J.C. Grecula, Christine L. Hann, Wade T. Iams, Puneeth Iyengar, Karen Kelly, Maya Khalil, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian R. Molina, César A. Moran, Saraswati Pokharel, Sonam Puri, Angel Qin, Chad G. Rusthoven, Jacob Sands, Rafael Santana-Dávila, Michael Shafique, Saiama N. Waqar, Kristina M. Gregory, Miranda Hughes
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
James L. Gulley, Arun Rajan, David R. Spigel, Nicholas Iannotti, Jason C. Chandler, Deborah Jean Lee Wong, Joseph W. Leach, W. Jeff Edenfield, Ding Wang, H. Grote, Anja von Heydebreck, Kevin M. Chin, Jean-Marie Cuillerot, Karen Kelly